European Archives - Page 97 of 1394 - European Medical Journal

Immunotherapy Benefits in Local Allergic Rhinitis - EMJ

Allergen Immunotherapy Shows Long-Term Benefits for Local Allergic Rhinitis

A 10-year study shows allergen immunotherapy provides lasting symptom relief in local allergic rhinitis and reduces the risk of asthma and new sensitizations.

Optimising Respiratory Care for a Sustainable Future

In this post-ERS 2025 follow-up podcast, we take the opportunity to discuss key data presented on sustainability in respiratory…

Blood Types A and B Linked to Higher Autoimmune Liver Disease Risk

New research shows that blood types A and B are linked to a higher risk of autoimmune liver disease.

Rare Gene Variants Linked to Higher Risk of ADHD

Discover how rare genetic variants significantly raise the risk of ADHD and affect brain development and life outcomes.

Joint Hypermobility Linked to Proprioceptive Deficits but Not Reduced Strength

A new study shows joint hypermobility impairs proprioception but does not reduce strength or functional stability, highlighting the need for targeted neuromuscular training.

Monitoring May Be Unnecessary in Frozen Embryo Transfers

New research shows that skipping ultrasound and hormone monitoring in selected frozen embryo transfer cycles does not affect pregnancy outcomes.

Ultra-Processed Foods Threaten Global Human Health, Experts Warn

Ultra-processed foods harm health and raise chronic disease risk. Experts call for regulation, warning labels, and support for minimally processed foods.

Gut Microbiota Imbalance Linked to Rapid Global Rise in IBD

Global research finds that gut microbiota dysbiosis strongly correlates with rising inflammatory bowel disease rates worldwide.

Obesity and Comorbidities Drive GLP-1 Agonist Use in Hidradenitis Suppurativa

GLP-1 agonists are more often prescribed for hidradenitis suppurativa patients with obesity, diabetes, and other metabolic conditions.

Targeted Cancer Drugs Linked to Long-Term Kidney Dysfunction

Targeted Cancer Drugs Linked to Long-Term Kidney Dysfunction

Certain cancer drugs, including CDK4/6, EGFR, VEGFR, and BRAF inhibitors, may raise the risk of progressive kidney dysfunction over two years.